322 related articles for article (PubMed ID: 25588687)
1. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
Cavera VL; Volski A; Chikindas ML
Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
[TBL] [Abstract][Full Text] [Related]
2. Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli.
Algburi A; Volski A; Chikindas ML
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25838136
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester.
Turovskiy Y; Cheryian T; Algburi A; Wirawan RE; Takhistov P; Sinko PJ; Chikindas ML
Infect Dis Obstet Gynecol; 2012; 2012():284762. PubMed ID: 23024575
[TBL] [Abstract][Full Text] [Related]
4. The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.
Noll KS; Prichard MN; Khaykin A; Sinko PJ; Chikindas ML
Antimicrob Agents Chemother; 2012 Apr; 56(4):1756-61. PubMed ID: 22252803
[TBL] [Abstract][Full Text] [Related]
5. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
Nagaraja P
Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
[TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.
Sundara Rajan S; Cavera VL; Zhang X; Singh Y; Chikindas ML; Sinko PJ
Antimicrob Agents Chemother; 2014 May; 58(5):2747-53. PubMed ID: 24566190
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
[TBL] [Abstract][Full Text] [Related]
9. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
Tomusiak A; Strus M; Heczko PB
Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
[TBL] [Abstract][Full Text] [Related]
10. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
[TBL] [Abstract][Full Text] [Related]
11. Spermicidal activity of the safe natural antimicrobial peptide subtilosin.
Sutyak KE; Anderson RA; Dover SE; Feathergill KA; Aroutcheva AA; Faro S; Chikindas ML
Infect Dis Obstet Gynecol; 2008; 2008():540758. PubMed ID: 18923673
[TBL] [Abstract][Full Text] [Related]
12. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
[TBL] [Abstract][Full Text] [Related]
13. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
14. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
Simoes JA; Aroutcheva A; Heimler I; Shott S; Faro S
Am J Obstet Gynecol; 2001 Nov; 185(5):1186-90. PubMed ID: 11717655
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility to antibiotics of microorganisms related with recurrent bacterial vaginosis].
Shopova E; Nikolov A; Dimitrov A
Akush Ginekol (Sofiia); 2011; 50(7):20-1. PubMed ID: 22452174
[TBL] [Abstract][Full Text] [Related]
16. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
17. Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus.
Muli F; Struthers JK
Antimicrob Agents Chemother; 1998 Jun; 42(6):1428-32. PubMed ID: 9624489
[TBL] [Abstract][Full Text] [Related]
18. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
[TBL] [Abstract][Full Text] [Related]
19. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
Aroutcheva AA; Simoes JA; Behbakht K; Faro S
Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
[TBL] [Abstract][Full Text] [Related]
20. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.
Austin MN; Beigi RH; Meyn LA; Hillier SL
J Clin Microbiol; 2005 Sep; 43(9):4492-7. PubMed ID: 16145097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
